Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27986910)

Published in J Immunol on December 16, 2016

Authors

Kilian Wistuba-Hamprecht1,2, Alexander Martens1,2, Benjamin Weide2, Karen Wei Weng Teng3, Henning Zelba4, Elena Guffart2, Jinmiao Chen5, Claus Garbe2, Evan W Newell6, Anis Larbi7, Graham Pawelec8,9,10

Author Affiliations

1: Department of Internal Medicine II, University Medical Center, 72072 Tübingen, Germany.
2: Department of Dermatology, University Medical Center, 72076 Tübingen, Germany.
3: Singapore Immunology Network, Biopolis, Agency for Science, Technology and Research, 138648 Singapore.
4: Department of Immunology, Institute for Cell Biology, University of Tübingen, 72076 Tübingen, Germany.
5: Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, #03-06, Singapore 138648, Singapore.
6: Singapore Immunology Network, Agency of Science, Technology and Research, Singapore 138648; and evan_newell@immunol.a-star.edu.sg.
7: Singapore Immunology Network, Biopolis, Agency for Science, Technology and Research, 138648 Singapore; graham.pawelec@uni-tuebingen.de Evan_Newell@immunol.a-star.edu.sg Anis_Larbi@immunol.a-star.edu.sg.
8: Department of Internal Medicine II, University Medical Center, 72072 Tübingen, Germany; graham.pawelec@uni-tuebingen.de Evan_Newell@immunol.a-star.edu.sg Anis_Larbi@immunol.a-star.edu.sg.
9: John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, United Kingdom; and.
10: Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE5 9NU, United Kingdom.